SIGNAL

Making stem cell therapy
accessible to humanity

Stem Cells - an extraordinary market but fragmented reality

Productno two products are alike
Evidencelittle published data
Costunpredictable and opaque
Protocolevery clinic does it differently
Manufacturingno common standard
Regulationrules differ by country

Flying across the world. What are you getting?


Treatments up to $50,000


A high price doesn't establish a high standard

~$5B

Estimated global market for unproven cell therapies

Offshore Exploration

CARIBBEAN · HONDURAS

Próspera

Roatán, a special jurisdiction in the Caribbean Sea

SOUTHEAST ASIA · MALAYSIA

Network School

Forest City, Johor, just across the border from Singapore

Japan is the right launchpad

Dialed CPCs


World Class Clinics

ASRM

Act on the Safety of Regenerative Medicine

The world's aging challenge is
already here

30%

of Japan's population is 65 or older.


5.84 million

projected to live with dementia by 2040

6.13 million

projected to have mild cognitive impairment by 2040

We are an Israel based company


Top Stem Cell Research Team

Life Sciences Core Facilities (LSCF), Weizmann Institute of Science

The war destroyed our omics lab

It was one of roughly 100 labs lost

We forged ahead


The Signal is the Medicine

MSCs release extracellular vesicles, growth factors and cytokines that mediate immunomodulatory and regenerative effects.

Priming boosts and standardizes the signal

Priming the producer cells strengthens the anti-inflammatory signal they release and makes it consistent batch to batch.

Standard MSC

Variable signal

Primed MSC

Priming

Strong, consistent signal

Anti-inflammatory factors

miRNA cargo

Boost

Standardize

OUR DATA

Exosomes drive neurogenesis, suppress senescence and restore cognition

Neurogenesis

Preclinical data (mouse and cell models). Investigational.

Cognition restoration

SASP Reduction

OUR DATA

Defining the signal

A huge change in lncRNA



Preclinical data. Investigational.

Our data

Exosomes go to the site of damage.

Intranasal exosomes accumulate in affected brains.

Exosomes accumulate in affected brains after intranasal delivery. Models: C57bl (healthy), ETH-1 (stroke), 6-OHDA (Parkinson's), 5xFAD (Alzheimer's), BTBR (autism).

Preclinical data (mouse and cell models). Investigational.

The Signal Clinic

Finding the signal in the noise

Stem cell therapy translation platform

We pull the signal from the noise in three areas

MOLECULAR

MANUFACTURING

CLINICAL

Signal Intelligence

AI to decode the therapeutic signal across biology, manufacturing, and clinical response

IDENTIFY

Which molecular features matter?

REPRODUCE

Which manufacturing conditions generate them?

VALIDATE

Which measurements demonstrate relevant biological activity?


SIGNAL
MIND


Primed MSC derived exosomes


Intranasal delivery


Brain health

FLAGSHIP PROTOCOL

Signal Mind flagship trial · Japan

Our flagship trial: measuring brain aging in Japan

Primed MSC-derived signal therapy, measured from baseline through scheduled follow-up.

Produced in Japan

Manufacturing

›

Administered in Japan

Partner clinic

Domestic and international patients

›

Price

Transparent, standardized pricing

WHAT WE MEASURE


Global cognition

MoCA, MMSE, ADAS-Cog

Memory

RAVLT (Rey Auditory Verbal Learning Test)

Attention and executive function

Trail Making A and B, Digit Symbol

Daily function and staging

CDR-SB, ADCS-ADL

Biomarkers and neuroimaging

MRI volumetrics, FDG-PET

Patient and caregiver reports

Structured questionnaires


Next in line

SIGNAL JOINT



Following

SIGNAL FACE



How the model grows to $100B+

Develop protocols

Partner clinics deliver

Measure outcomes

License to more clinics

1

2

3

4

$100B+

Market ambition

US · Israel · Japan

Team

ADVISORS


Prof. Gadi Turgeman
Ariel University

Prof. Dani Offen
Tel Aviv University

Dr. Takahiro Ochiya
Tokyo Medical University

Asher Miller

CEO

Proven VC backed biotech entrepreneur in biomanufacturing and gene and cell therapy.

Tal Rusak, MBA

COO

Bioinformatics and AI background with extensive operator experience.

Tomer Landsberger, PhD

CSO

Leading aging scientist and Weizmann PhD.


$1.8M


Build the platform

Activate Signal Mind protocol

Goal: 100 patients treated

signal.clinic